Home/Pipeline/161Tb‑labeled therapeutic agent

161Tb‑labeled therapeutic agent

Targeted cancer therapy

Phase 1Active

Key Facts

Indication
Targeted cancer therapy
Phase
Phase 1
Status
Active
Company

About Cyclotek

Australian PET radiopharma supplier with a national cyclotron network and proprietary tracer portfolio.

View full company profile